Acute Hepatitis in Israeli Travelers
ConclusionsEnterically transmitted hepatitis is the main causes of viral hepatitis among travelers. HEV is an emerging disease and has become the most common hepatitis among Israeli travelers. Although an efficacious vaccine has been developed, no licensed HEV vaccine is yet available. Although hepatitis A vaccine is highly efficacious, safe, and easily available, there is a stable number of HAV cases.
Source: Journal of Travel Medicine - Category: Infectious Diseases Authors: Tamar Lachish, Moshik Tandlich, Eli Schwartz Tags: ORIGINAL ARTICLE Source Type: research
More News: Epidemiology | Hepatitis | Hepatitis A | Hepatitis B | Hepatitis C | Hepatitis Vaccine | Infectious Diseases | Israel Health | Middle East Health | Study | Vaccines